Debate: Yes, Immunotherapy is the Standard First-line Therapy for mRCC

Date 23 November 2018
Event ESMO Preceptorship on Metastatic Bladder and Kidney Cancer Zurich November 2018
Session Session 4 Debates of the Day
Topics Renal Cell Cancer
Immunotherapy
Presenter V. Grünwald, DE